Why the study?
Does increasing candesartan to the maximal dose (12 mg/day) improve albuminuria and hypertension in Japanese type 2 diabetic patients?
Does increasing candesartan to the maximal dose (12 mg/day) improve albuminuria and hypertension in Japanese type 2 diabetic patients?
Increasing candesartan to the maximal dose of 12 mg/day in Japan provides effective renoprotection and blood pressure control in type 2 diabetic patients.
May support higher-dose candesartan for albuminuria in diabetes; leaves open need for randomized confirmation.
No takes yet. Share an insight, caveat, or question.
Oikawa et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: